Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting iron metabolism in drug discovery and delivery
Bart J. Crielaard, Twan Lammers, Stefano Rivella
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 6, pp. 400-423
Open Access | Times Cited: 317

Showing 1-25 of 317 citing articles:

Ferroptosis is a type of autophagy-dependent cell death
Bo Zhou, Jiao Liu, Rui Kang, et al.
Seminars in Cancer Biology (2019) Vol. 66, pp. 89-100
Closed Access | Times Cited: 819
The tumor suppressor protein p53 and the ferroptosis network
Rui Kang, Guido Kroemer, Daolin Tang
Free Radical Biology and Medicine (2018) Vol. 133, pp. 162-168
Open Access | Times Cited: 542
Iron metabolism and iron disorders revisited in the hepcidin era
Clara Camaschella, Antonella Nai, Laura Silvestri
Haematologica (2020) Vol. 105, Iss. 2, pp. 260-272
Open Access | Times Cited: 522
Iron and Cancer
Suzy V. Torti, David H. Manz, Bibbin T. Paul, et al.
Annual Review of Nutrition (2018) Vol. 38, Iss. 1, pp. 97-125
Open Access | Times Cited: 351
Haemochromatosis
Pierre Brissot, Antonello Pietrangelo, Paul C. Adams, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 335
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Ying Shen, Xin Li, Dandan Dong, et al.
PubMed (2018) Vol. 8, Iss. 6, pp. 916-931
Closed Access | Times Cited: 320
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease
Ye Tian, Juan Lü, Xiaoqian Hao, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1796-1812
Open Access | Times Cited: 307
The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression
Yuqing Wu, Si-Wei Zhang, Xiaoxiao Gong, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 280
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
Christian B. Billesbølle, Caleigh M. Azumaya, Rachael C. Kretsch, et al.
Nature (2020) Vol. 586, Iss. 7831, pp. 807-811
Open Access | Times Cited: 264
Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO 3 nanoformulation triggers ferroptosis in target tumor cells
Chencheng Xue, Menghuan Li, Yang Zhao, et al.
Science Advances (2020) Vol. 6, Iss. 18
Open Access | Times Cited: 260
Iron Metabolism in Cancer
Yafang Wang, Yu Lei, Jian Ding, et al.
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 95-95
Open Access | Times Cited: 257
Iron Deficiency in Heart Failure
Stephan von Haehling, Nicole Ebner, Ruben Evertz, et al.
JACC Heart Failure (2018) Vol. 7, Iss. 1, pp. 36-46
Open Access | Times Cited: 254
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
Junlin Liu, Yonggang Fan, Zhengsheng Yang, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 241
Emerging mechanisms and targeted therapy of ferroptosis in cancer
Haiyan Wang, Yan Cheng, Chao Mao, et al.
Molecular Therapy (2021) Vol. 29, Iss. 7, pp. 2185-2208
Open Access | Times Cited: 227
Hepcidin and Anemia: A Tight Relationship
Alessia Pagani, Antonella Nai, Laura Silvestri, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 202
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
Xinbo Wang, Yueqing Chen, Xudong Wang, et al.
Cancer Research (2021) Vol. 81, Iss. 20, pp. 5217-5229
Open Access | Times Cited: 182
Heme: emergent roles of heme in signal transduction, functional regulation and as catalytic centres
Tôru Shimizu, Alžběta Lengálová, Václav Martínek, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 24, pp. 5624-5657
Closed Access | Times Cited: 180
Iron deficiency anaemia: pathophysiology, assessment, practical management
Aditi Kumar, Esha Sharma, A Marley, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000759-e000759
Open Access | Times Cited: 178
Classical and Nonclassical Intercellular Communication in Senescence and Ageing
Juan Fafián‐Labora, Ana O’Loghlen
Trends in Cell Biology (2020) Vol. 30, Iss. 8, pp. 628-639
Open Access | Times Cited: 169
Iron metabolism: pathophysiology and pharmacology
Karolin Roemhild, Finn von Maltzahn, Ralf Weiskirchen, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 8, pp. 640-656
Open Access | Times Cited: 165
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Jodie L. Babitt, Michele F. Eisenga, Volker H. Haase, et al.
Kidney International (2021) Vol. 99, Iss. 6, pp. 1280-1295
Open Access | Times Cited: 164
Iron Metabolism and Immune Regulation
Shuo Ni, Yin Yuan, Yanbin Kuang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 153
Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis
Fan Yu, Qianping Zhang, Hanyu Liu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Iron homeostasis in host and gut bacteria – a complex interrelationship
Yohannes Seyoum, Kaleab Baye, Christèle Humblot
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 122
Iron Homeostasis Disorder and Alzheimer’s Disease
Yu Peng, Xuejiao Chang, Minglin Lang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12442-12442
Open Access | Times Cited: 112
Page 1 - Next Page

Scroll to top